Cheng-Wei Lin

492 total citations
33 papers, 366 citations indexed

About

Cheng-Wei Lin is a scholar working on Endocrinology, Diabetes and Metabolism, Rehabilitation and Surgery. According to data from OpenAlex, Cheng-Wei Lin has authored 33 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Endocrinology, Diabetes and Metabolism, 10 papers in Rehabilitation and 6 papers in Surgery. Recurrent topics in Cheng-Wei Lin's work include Diabetic Foot Ulcer Assessment and Management (10 papers), Wound Healing and Treatments (9 papers) and Pressure Ulcer Prevention and Management (4 papers). Cheng-Wei Lin is often cited by papers focused on Diabetic Foot Ulcer Assessment and Management (10 papers), Wound Healing and Treatments (9 papers) and Pressure Ulcer Prevention and Management (4 papers). Cheng-Wei Lin collaborates with scholars based in Taiwan and United States. Cheng-Wei Lin's co-authors include Yu‐Yao Huang, Shih‐Yuan Hung, Chung‐Huei Huang, Chia-Hung Lin, Tsung-Ying Sun, Sheng-Ta Hsieh, I‐Wen Chen, David G. Armstrong, Brend Ray‐Sea Hsu and Pi‐Hua Liu and has published in prestigious journals such as Medicine, Canadian Medical Association Journal and Frontiers in Endocrinology.

In The Last Decade

Cheng-Wei Lin

33 papers receiving 355 citations

Peers

Cheng-Wei Lin
Deborah Hilton Australia
DM Anisuzzaman United States
Yash Patel United States
Daniel Lorenz United States
Behrouz Rostami United States
Furqan Haq United States
Cheng-Wei Lin
Citations per year, relative to Cheng-Wei Lin Cheng-Wei Lin (= 1×) peers Raviraja V Acharya

Countries citing papers authored by Cheng-Wei Lin

Since Specialization
Citations

This map shows the geographic impact of Cheng-Wei Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng-Wei Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng-Wei Lin more than expected).

Fields of papers citing papers by Cheng-Wei Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheng-Wei Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng-Wei Lin. The network helps show where Cheng-Wei Lin may publish in the future.

Co-authorship network of co-authors of Cheng-Wei Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Cheng-Wei Lin. A scholar is included among the top collaborators of Cheng-Wei Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheng-Wei Lin. Cheng-Wei Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lin, Cheng-Wei, et al.. (2025). Serum adropin levels as a potential biomarker for predicting diabetic kidney disease progression. Frontiers in Endocrinology. 16. 1511730–1511730. 1 indexed citations
2.
3.
Lin, Cheng-Wei, Shih‐Yuan Hung, & I‐Wen Chen. (2023). A study of glycemic perturbations following two doses of COVID-19 vaccination for patients with diabetes: the impacts of vaccine type and anti-diabetes drugs. Diabetology & Metabolic Syndrome. 15(1). 81–81. 1 indexed citations
5.
Lin, Cheng-Wei, David G. Armstrong, Chung‐Huei Huang, et al.. (2022). Diabetic foot disease in subjects with End-stage renal Disease: A nationwide study over 14 years highlighting an emerging threat. Diabetes Research and Clinical Practice. 193. 110134–110134. 7 indexed citations
6.
Lin, Cheng-Wei. (2022). Colchicine May Interfere With the Efficacy of the Adenoviral Vector–Based Vaccine for COVID-19. PubMed. 15. 737384421–737384421. 1 indexed citations
7.
Lin, Cheng-Wei, Hui‐Mei Yang, Shih‐Yuan Hung, I‐Wen Chen, & Yu‐Yao Huang. (2021). The analysis for time of referral to a medical center among patients with diabetic foot infection. BMC Family Practice. 22(1). 16–16. 12 indexed citations
8.
Lin, Chia-Hung, David G. Armstrong, Pi‐Hua Liu, et al.. (2021). Survival of Patients Following First Diagnosis of Diabetic Foot Complications: A Nationwide 15-Year Longitudinal Analysis. Frontiers in Endocrinology. 12. 801324–801324. 7 indexed citations
9.
Lin, Cheng-Wei, et al.. (2020). Association of unhealthy dietary behaviors with renal function decline in patients with diabetes. BMJ Open Diabetes Research & Care. 8(1). e000743–e000743. 7 indexed citations
10.
Lin, Cheng-Wei, David G. Armstrong, Chia-Hung Lin, et al.. (2019). Nationwide trends in the epidemiology of diabetic foot complications and lower-extremity amputation over an 8-year period. BMJ Open Diabetes Research & Care. 7(1). e000795–e000795. 63 indexed citations
11.
Hung, Shih‐Yuan, Jiun‐Ting Yeh, Kuan‐Hsing Chen, et al.. (2019). Amino acids and wound healing in people with limb-threatening diabetic foot ulcers. Journal of Diabetes and its Complications. 33(10). 107403–107403. 17 indexed citations
12.
Huang, Chung‐Huei, Cheng‐Hsun Chiu, I‐Wen Chen, et al.. (2018). Antimicrobial resistance and outcomes of community-onset bacterial bloodstream infections in patients with type 2 diabetes. Journal of Global Antimicrobial Resistance. 15. 271–276. 10 indexed citations
14.
Lin, Cheng-Wei, Brend Ray‐Sea Hsu, Hui‐Mei Yang, et al.. (2016). Effect of limb preservation status and body mass index on the survival of patients with limb-threatening diabetic foot ulcers. Journal of Diabetes and its Complications. 31(1). 180–185. 27 indexed citations
15.
Hung, Shih‐Yuan, Yu‐Yao Huang, Lung‐An Hsu, et al.. (2015). Treatment for Diabetic Foot Ulcers Complicated by Major Cardiac Events. Canadian Journal of Diabetes. 39(3). 183–187. 10 indexed citations
16.
Lin, Cheng-Wei, Lung‐An Hsu, Chun‐Chi Chen, et al.. (2010). C-reactive protein as an outcome predictor for percutaneous transluminal angioplasty in diabetic patients with peripheral arterial disease and infected foot ulcers. Diabetes Research and Clinical Practice. 90(2). 167–172. 47 indexed citations
17.
Hsieh, Sheng-Ta, et al.. (2007). Cluster based solution exploration strategy for multiobjective particle swarm optimization. 295–300. 2 indexed citations
18.
Sun, Tsung-Ying, et al.. (2006). Floorplanning based on particle swarm optimization. 5 pp.–5 pp.. 24 indexed citations
19.
Lin, Cheng-Wei, Sheng-Ta Hsieh, & Tsung-Ying Sun. (2005). Particle Swarm Optimization Incorporated with Dis-turbance for Improving the Efficiency of Macrocell Overlap Removal and Placement.. International Conference on Artificial Intelligence. 122–128. 2 indexed citations
20.
Hsieh, Sheng-Ta, Cheng-Wei Lin, & Tsung-Ying Sun. (2005). Particle swarm optimization for macrocell overlap removal and placement. 177–180. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026